Cerity Partners LLC Apellis Pharmaceuticals, Inc. Transaction History
Cerity Partners LLC
- $48.7 Billion
- Q1 2025
A detailed history of Cerity Partners LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Cerity Partners LLC holds 54,444 shares of APLS stock, worth $890,703. This represents 0.0% of its overall portfolio holdings.
Number of Shares
54,444
Previous 46,667
16.66%
Holding current value
$890,703
Previous $1.49 Million
20.08%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding APLS
# of Institutions
295Shares Held
124MCall Options Held
921KPut Options Held
761K-
Wellington Management Group LLP Boston, MA12.3MShares$201 Million0.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.2MShares$200 Million4.32% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$195 Million20.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$166 Million0.0% of portfolio
-
Morgan Stanley New York, NY9.63MShares$157 Million0.02% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $1.8B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...